Viral Suppression of HIV Infection
Conditions
Brief summary
The purpose of the study is to screen the optimal intervention strategies to rapid establish the protective barriers against HIV-infection by maximally decreasing the viremia among HIV- infected patients.
Detailed description
Sexual transmission became the primary route of HIV transmission in China and heterosexual transmission also contributed greatly to HIV epidemic which was mostly reported in South-west rural areas. In past years, Yunnan has experienced powerful campaign of scaling-up the HIV identification as well as antrertroviral therapy. This study will investigate how to reach the last two of HIV'90-90-90 targets': to provide antiretroviral therapy (ART) for 90% of who diagnosed HIV infection and to achieve viral suppression for 90% of those treated. The study population consists of participants who received an newly diagnosed HIV infection within the study period. All rerolled participants will be randomized into different study group. In intervention group, medical institutions will provide patients personal involved intervention strategies which guided by frequent viral load detection, and providing of the dosage form of 400 mg EFV in their antiviral therapy. Main assessment measures are viral suppression rate of HIV-infected patients and treatment coverage .
Interventions
Medical institutions will provide personal involved intervention strategies for patients which guided by viral load testing monthly until viral load drop below the detection limit.
The dosage of 400mg EFV will be used in the antiviral therapy.
Sponsors
Study design
Eligibility
Inclusion criteria
* HIV-positive participants who received an newly diagnosed HIV infection within the study period * Having a current residential address inside of pilot site limits * Eighteen years old or above * HIV transmission is heterosexual contact
Exclusion criteria
* IDU * Having severe mental disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Viral suppression of HIV-infected patients | 12 months |
Secondary
| Measure | Time frame |
|---|---|
| Treatment coverage | 12 months |
Countries
China